In recent years, several epidemiological studies have sought to determine the anti-nausea drug Zofran’s effects in pregnant women taking it during the first trimester of pregnancy as a treatment for morning sickness. Their results have suggested that Zofran’s active ingredient, Ondansetron, may increase the risk of severe child birth defects, including congenital heart disease and cleft palate. As a result, Banville Law is investigating the link and is currently accepting Zofran lawsuits in New York.
Banville Law Joins National Alliance Of Zofran Lawyers
The managing partner of Banville Law has joined a national alliance of lawyers filing lawsuits on behalf of children and families who may have suffered defects as a result of taking Zofran.
Mr. Banville joins this alliance of Michael Monheit from Monheit Law, Rob Jenner from Janet, Jenner & Suggs, Elizabeth Graham from Grant & Eisenhofer, and Brian Mittman from Markhoff & Mittman.
How Can A Lawyer Help Me?
If you took Zofran during the first trimester of your pregnancy and your child was born with a congenital birth defect, then you may be entitled to compensation for your pain and suffering, among other things. At Banville Law, we have teamed up with leading pharmaceutical lawyers and experts that are here to listen to your specific case and evaluate your legal options.
As a New York personal injury law firm, we are here to fight for the rights of New Yorkers. If you, a loved one, or a friend may have been injured because of Zofran, call the New York defective drug lawyers at Banville Law today. We will help you.
What Types Of Lawsuits Are Being Filed In New York?
To date, there have been no Zofran lawsuits filed in the state of New York. However, we do expect this to change very soon. The lawsuits being filed are individual personal injury claims against the manufacturer alleging that:
- Zofran was unsafe to promote off-label to mothers for morning sickness
- the manufacturer knew of cases of child birth defects where the mother took Zofran for morning sickness
- the manufacturer failed to warn that Zofran could increase the risk of child birth defects
To read more about the latest Zofran lawsuits, click here.
What Child Birth Defects Are Being Linked To The Drug?
The epidemiological studies we mentioned earlier have suggested that Zofran increases the risk of:
- Cleft Palate (an orofacial cleft)
- Atrial Septal Defects (ASD – a congenital heart defect)
- Ventricular Septal Defects (VSD – a congenital heart defect)
Based on the studies, we are accepting Zofran lawsuits from New York where:
- You were prescribed Zofran and took Zofran for morning sickness during the first trimester
- Your child was born with or subsequently diagnosed with a congenital heart defect or a cleft lip and/or cleft palate
If your child suffered a defect that was not listed above, please call us. We are investigating the etiology of various defects and may accept your case.
Birth Defect Statistics
A study performed by the New York Health Department on birth data in New York from 2000 to 2002 reveals that the average occurrence of a major birth defect per 10,000 live births was 196.8.
Atrial Septal Defect
Specifically, the study showed that in the same time period, there were 29.9 reported Atrial Septal Defects (ASD’s) per 10,000 live births in the entire state of New York.
Cleft Palate And/Or Cleft Lip
13.2 instances per 10,000 live births of cleft lip with and without cleft palate were reported in the entire state of New York between 2000 and 2002.
Despite this relatively low percentage per 10,000, the studies suggest that Zofran may have lead to an increase in the risk of these birth defects. Call our New York law offices today to begin your investigation into whether you have a Zofran lawsuit.